Shiqin Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shiqin Chen has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Tian Lv
Department of Neurology Zhuji Affiliated Hospital of Wenzhou Medical University Zhuji China
4 shared publications Tianjiao Meng
Department of Neurology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, China
3 shared publicationsXianhong Wu
Department of Neurology, Yuhuan Second People’s Hospital, Yuhuan 317605, China
3 shared publicationsQinwen Fei
Department of Geriatrics, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, China
2 shared publicationsTian Lv
Department of Neurology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, China
2 shared publicationsWanyi Lin
Department of Neurology, Qingtian People’s Hospital, Zhejiang, China
2 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (32) , e50148
Modified cardiometabolic index and stroke risk: Evidence from the CHARLS cohort
The association between the modified cardiometabolic index (MCMI) and stroke risk remains unclear. This study aimed to investigate the relationship between MCMI and incident stroke. A total of 8167 participants from the China Health and Retirement Longitudinal Study (baseline 2011) were included. MCMI was calculated as ln[triglycerides × fasting blood glucose/ high-density lipoprotein cholesterol] × waist circumference/ height. Incident stroke was defined as self-reported physician-diagnosed stroke during follow-up through 2020. Cox proportional hazards regression, restricted cubic spline (RCS) modeling, and subgroup analyses were performed to examine the association. Time-dependent receiver operating characteristic (ROC) analysis was used to compare the predictive performance of MCMI with that of the cardiometabolic index (CMI). Over 9 years of follow-up, higher MCMI levels were associated with increased stroke risk (hazard ratio [HR] = 1.32, 95% confidence interval [CI]: 1.20–1.46). Quartile analyses confirmed this trend, with the highest quartile showing the greatest risk compared with the lowest (HR = 2.30, 95% CI: 1.80–2.94). RCS analysis revealed a nonlinear relationship (P for nonlinearity = 0.002). Subgroup analyses suggested potential heterogeneity across marital status and residential location. ROC analysis showed that the MCMI consistently yielded higher AUC values than the CMI at 3 years (0.72 vs 0.70), 5 years (0.75 vs 0.73), 7 years (0.77 vs 0.75), and 8 years (0.72 vs 0.70), with all DeLong’s test P-values < 0.05. Higher MCMI levels were positively associated with stroke risk. Although MCMI demonstrated slightly better predictive performance than CMI, the improvement was limited. These findings support an association rather than direct clinical applicability. Additional large-scale prospective studies and validation analyses are required before its routine use in clinical risk stratification can be considered.
- 7 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (32) , e50148
Open AccessModified cardiometabolic index and stroke risk: Evidence from the CHARLS cohort
The association between the modified cardiometabolic index (MCMI) and stroke risk remains unclear. This study aimed to investigate the relationship between MCMI and incident stroke. A total of 8167 participants from the China Health and Retirement Longitudinal Study (baseline 2011) were included. MCMI was calculated as ln[triglycerides × fasting blood glucose/ high-density lipoprotein cholesterol] × waist circumference/ height. Incident stroke was defined as self-reported physician-diagnosed stroke during follow-up through 2020. Cox proportional hazards regression, restricted cubic spline (RCS) modeling, and subgroup analyses were performed to examine the association. Time-dependent receiver operating characteristic (ROC) analysis was used to compare the predictive performance of MCMI with that of the cardiometabolic index (CMI). Over 9 years of follow-up, higher MCMI levels were associated with increased stroke risk (hazard ratio [HR] = 1.32, 95% confidence interval [CI]: 1.20–1.46). Quartile analyses confirmed this trend, with the highest quartile showing the greatest risk compared with the lowest (HR = 2.30, 95% CI: 1.80–2.94). RCS analysis revealed a nonlinear relationship (P for nonlinearity = 0.002). Subgroup analyses suggested potential heterogeneity across marital status and residential location. ROC analysis showed that the MCMI consistently yielded higher AUC values than the CMI at 3 years (0.72 vs 0.70), 5 years (0.75 vs 0.73), 7 years (0.77 vs 0.75), and 8 years (0.72 vs 0.70), with all DeLong’s test P-values < 0.05. Higher MCMI levels were positively associated with stroke risk. Although MCMI demonstrated slightly better predictive performance than CMI, the improvement was limited. These findings support an association rather than direct clinical applicability. Additional large-scale prospective studies and validation analyses are required before its routine use in clinical risk stratification can be considered.
- Open Access
- 14 March 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1528567
Joint association of sleep duration and depression with new-onset hearing loss: a national cohort study
Background: Hearing loss, a global health burden, is closely associated with depression and sleep disorders. However, the combined effects of sleep duration and depression on hearing loss risk remain unclear.Methods: Data from the China Health and Retirement Longitudinal Study (CHARLS) were analyzed, including 6,374 adults aged 45 and older. Cox proportional hazards models assessed the relationship between depression, sleep duration, and hearing loss. Mediation analysis explored the potential mediating roles of CESD-10 score and sleep duration on new-onset hearing loss. Subgroup analyses by age, sex, and BMI were also conducted.Results: Over a 7-year follow-up, 1,422 participants developed hearing loss. Both short sleep duration and high CESD-10 scores were independently associated with increased risk of hearing loss. Participants with long sleep duration but depression had a hazards ratio (HR) of 1.59 (95% CI: 1.35, 1.87) for hearing loss. Mediation analysis showed that sleep duration mediated 10.1% of the association between CESD-10 score and hearing loss, while CESD-10 score mediated 70.8% of the relationship between sleep duration and hearing loss.Conclusion: This study highlights the significant and interconnected roles of sleep duration and depression in the development of hearing loss. Interventions addressing both sleep and depression may offer more effective strategies for preventing and managing hearing loss.
- 14 March 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1528567
Open AccessJoint association of sleep duration and depression with new-onset hearing loss: a national cohort study
Background: Hearing loss, a global health burden, is closely associated with depression and sleep disorders. However, the combined effects of sleep duration and depression on hearing loss risk remain unclear.Methods: Data from the China Health and Retirement Longitudinal Study (CHARLS) were analyzed, including 6,374 adults aged 45 and older. Cox proportional hazards models assessed the relationship between depression, sleep duration, and hearing loss. Mediation analysis explored the potential mediating roles of CESD-10 score and sleep duration on new-onset hearing loss. Subgroup analyses by age, sex, and BMI were also conducted.Results: Over a 7-year follow-up, 1,422 participants developed hearing loss. Both short sleep duration and high CESD-10 scores were independently associated with increased risk of hearing loss. Participants with long sleep duration but depression had a hazards ratio (HR) of 1.59 (95% CI: 1.35, 1.87) for hearing loss. Mediation analysis showed that sleep duration mediated 10.1% of the association between CESD-10 score and hearing loss, while CESD-10 score mediated 70.8% of the relationship between sleep duration and hearing loss.Conclusion: This study highlights the significant and interconnected roles of sleep duration and depression in the development of hearing loss. Interventions addressing both sleep and depression may offer more effective strategies for preventing and managing hearing loss.
- Open Access
- 3 March 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1473802
J-shaped association of neutrophil-to-lymphocyte ratio with all-cause mortality and linear association with cardiovascular mortality in stroke survivors
Background: The correlation between systemic inflammation and stroke has been well-established. Notably, the neutrophil-to-lymphocyte ratio (NLR) has been linked to poor outcomes and increased short-term mortality in acute ischemic stroke (AIS). This study aims to explore the association between NLR and long-term mortality among stroke survivors.Methods: This study analyzed data from 1,229 stroke survivors enrolled in the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2018. The participants were categorized according to quartiles of NLR level. Multivariate Cox regression and restricted cubic splines (RCS) were applied to evaluate the relationship between NLR and all-cause and cardiovascular disease (CVD) mortality.Results: Over a median follow-up of 6.41 years, 485 deaths were recorded. After multivariate adjustment, individuals in the highest NLR quartile (Q4) demonstrated significantly higher risks of all-cause mortality (hazard ratio [HR] = 1.58, 95% confidence interval [CI]: 1.06–2.34) and CVD mortality (HR = 1.90, 95% CI: 1.07–3.37) compared to those in the lowest quartile (Q1). RCS analysis revealed a J-shaped relationship between NLR and all-cause mortality and a linear relationship with CVD mortality.Conclusion: These findings suggest a J-shaped association between NLR and all-cause mortality, along with a linear relationship between NLR and CVD mortality in stroke survivors.
- 3 March 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1473802
Open AccessJ-shaped association of neutrophil-to-lymphocyte ratio with all-cause mortality and linear association with cardiovascular mortality in stroke survivors
Background: The correlation between systemic inflammation and stroke has been well-established. Notably, the neutrophil-to-lymphocyte ratio (NLR) has been linked to poor outcomes and increased short-term mortality in acute ischemic stroke (AIS). This study aims to explore the association between NLR and long-term mortality among stroke survivors.Methods: This study analyzed data from 1,229 stroke survivors enrolled in the National Health and Nutrition Examination Survey (NHANES) from 2001 to 2018. The participants were categorized according to quartiles of NLR level. Multivariate Cox regression and restricted cubic splines (RCS) were applied to evaluate the relationship between NLR and all-cause and cardiovascular disease (CVD) mortality.Results: Over a median follow-up of 6.41 years, 485 deaths were recorded. After multivariate adjustment, individuals in the highest NLR quartile (Q4) demonstrated significantly higher risks of all-cause mortality (hazard ratio [HR] = 1.58, 95% confidence interval [CI]: 1.06–2.34) and CVD mortality (HR = 1.90, 95% CI: 1.07–3.37) compared to those in the lowest quartile (Q1). RCS analysis revealed a J-shaped relationship between NLR and all-cause mortality and a linear relationship with CVD mortality.Conclusion: These findings suggest a J-shaped association between NLR and all-cause mortality, along with a linear relationship between NLR and CVD mortality in stroke survivors.
- Open Access
- 20 January 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1517663
Association of serum neurofilament light chain with cognitive impairment: findings from the National Health and Nutrition Examination Survey
Background: Serum Neurofilament Light chain (NfL) is a promising biomarker of neuronal damage, used to assess the extent of neuronal injury and neurodegeneration, and it is widely applied in the diagnosis of neurodegenerative disease and monitoring disease progression. This article aims to determine whether serum NfL associated with cognitive level.Methods: Using NHANES data, we conducted an analysis of cognitive test results for 450 adults aged 60 years and older and examined their correlation with serum NfL levels. When exploring the association between cognitive test scores and serum NfL levels, regression models and restricted cubic spline (RCS) regression models were employed to adjust for potential confounding factors. The least absolute shrinkage and selection operator (LASSO) regression was applied for identifying key cognitive impairment factors, which was then included in the establishment of a risk prediction nomogram model, with the receiver operating characteristic (ROC) curve being built to evaluate its discriminatory power for cognitive impairment.Results: It was found that there is a strong positive correlation between serum NfL levels and both low total cognitive function (total-CF) OR: 1.028 (95%CI = 1.015–1.041 p < 0.001) and low Digit Symbol Substitution Test (DSST) OR: 1.026 (95%CI = 1.003–1.050, p = 0.027). Furthermore, using the RCS model, we observed a linear trend in the relationship between NfL and low total-CF. The nomogram model based on NfL identified by LASSO regression displayed a considerable predicative value for low total-CF, with an area under the curve [AUC = 85.6% (81.6–89.3%)].Conclusion: There is a strong correlation between serum NfL levels and cognitive function, especially DSST, which reflects attention and information processing abilities, as well as overall cognitive function, but not memory and language fluency. Thus, NfL may serve as a serum biomarker for dementia monitoring.
- 20 January 2025
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1517663
Open AccessAssociation of serum neurofilament light chain with cognitive impairment: findings from the National Health and Nutrition Examination Survey
Background: Serum Neurofilament Light chain (NfL) is a promising biomarker of neuronal damage, used to assess the extent of neuronal injury and neurodegeneration, and it is widely applied in the diagnosis of neurodegenerative disease and monitoring disease progression. This article aims to determine whether serum NfL associated with cognitive level.Methods: Using NHANES data, we conducted an analysis of cognitive test results for 450 adults aged 60 years and older and examined their correlation with serum NfL levels. When exploring the association between cognitive test scores and serum NfL levels, regression models and restricted cubic spline (RCS) regression models were employed to adjust for potential confounding factors. The least absolute shrinkage and selection operator (LASSO) regression was applied for identifying key cognitive impairment factors, which was then included in the establishment of a risk prediction nomogram model, with the receiver operating characteristic (ROC) curve being built to evaluate its discriminatory power for cognitive impairment.Results: It was found that there is a strong positive correlation between serum NfL levels and both low total cognitive function (total-CF) OR: 1.028 (95%CI = 1.015–1.041 p < 0.001) and low Digit Symbol Substitution Test (DSST) OR: 1.026 (95%CI = 1.003–1.050, p = 0.027). Furthermore, using the RCS model, we observed a linear trend in the relationship between NfL and low total-CF. The nomogram model based on NfL identified by LASSO regression displayed a considerable predicative value for low total-CF, with an area under the curve [AUC = 85.6% (81.6–89.3%)].Conclusion: There is a strong correlation between serum NfL levels and cognitive function, especially DSST, which reflects attention and information processing abilities, as well as overall cognitive function, but not memory and language fluency. Thus, NfL may serve as a serum biomarker for dementia monitoring.
- Open Access
- 1 August 2024
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 18, 1416431
Heart failure causally affects the brain cortical structure: a Mendelian randomization study
Background: The effects of heart failure (HF) on cortical brain structure remain unclear. Therefore, the present study aimed to investigate the causal effects of heart failure on cortical structures in the brain using Mendelian randomization (MR) analysis.Methods: We conducted a two-sample MR analysis utilizing genetically-predicted HF trait, left ventricular ejection fraction (LVEF), and N-terminal prohormone brain natriuretic peptide (NT-proBNP) levels to examine their effects on the cortical surface area (SA) and thickness (TH) across 34 cortical brain regions. Genome-wide association study summary data were extracted from studies by Rasooly (1,266,315 participants) for HF trait, Schmidt (36,548 participants) for LVEF, the SCALLOP consortium (21,758 participants) for NT-proBNP, and the ENIGMA Consortium (51,665 participants) for cortical SA and TH. A series of MR analyses were employed to exclude heterogeneity and pleiotropy, ensuring the stability of the results. Given the exploratory nature of the study, p-values between 1.22E−04 and 0.05 were considered suggestive of association, and p-values below 1.22E−04 were defined as statistically significant.Results: In this study, we found no significant association between HF and cortical TH or SA (all p > 1.22E−04). We found that the HF trait and elevated NT-proBNP levels were not associated with cortical SA, but were suggested to decrease cortical TH in the pars orbitalis, lateral orbitofrontal cortex, temporal pole, lingual gyrus, precuneus, and supramarginal gyrus. Reduced LVEF was primarily suggested to decrease cortical SA in the isthmus cingulate gyrus, frontal pole, postcentral gyrus, cuneus, and rostral middle frontal gyrus, as well as TH in the postcentral gyrus. However, it was suggested to causally increase in the SA of the posterior cingulate gyrus and medial orbitofrontal cortex and the TH of the entorhinal cortex and superior temporal gyrus.Conclusion: We found 15 brain regions potentially affected by HF, which may lead to impairments in cognition, emotion, perception, memory, language, sensory processing, vision, and executive control in HF patients.
- 1 August 2024
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 18, 1416431
Open AccessHeart failure causally affects the brain cortical structure: a Mendelian randomization study
Background: The effects of heart failure (HF) on cortical brain structure remain unclear. Therefore, the present study aimed to investigate the causal effects of heart failure on cortical structures in the brain using Mendelian randomization (MR) analysis.Methods: We conducted a two-sample MR analysis utilizing genetically-predicted HF trait, left ventricular ejection fraction (LVEF), and N-terminal prohormone brain natriuretic peptide (NT-proBNP) levels to examine their effects on the cortical surface area (SA) and thickness (TH) across 34 cortical brain regions. Genome-wide association study summary data were extracted from studies by Rasooly (1,266,315 participants) for HF trait, Schmidt (36,548 participants) for LVEF, the SCALLOP consortium (21,758 participants) for NT-proBNP, and the ENIGMA Consortium (51,665 participants) for cortical SA and TH. A series of MR analyses were employed to exclude heterogeneity and pleiotropy, ensuring the stability of the results. Given the exploratory nature of the study, p-values between 1.22E−04 and 0.05 were considered suggestive of association, and p-values below 1.22E−04 were defined as statistically significant.Results: In this study, we found no significant association between HF and cortical TH or SA (all p > 1.22E−04). We found that the HF trait and elevated NT-proBNP levels were not associated with cortical SA, but were suggested to decrease cortical TH in the pars orbitalis, lateral orbitofrontal cortex, temporal pole, lingual gyrus, precuneus, and supramarginal gyrus. Reduced LVEF was primarily suggested to decrease cortical SA in the isthmus cingulate gyrus, frontal pole, postcentral gyrus, cuneus, and rostral middle frontal gyrus, as well as TH in the postcentral gyrus. However, it was suggested to causally increase in the SA of the posterior cingulate gyrus and medial orbitofrontal cortex and the TH of the entorhinal cortex and superior temporal gyrus.Conclusion: We found 15 brain regions potentially affected by HF, which may lead to impairments in cognition, emotion, perception, memory, language, sensory processing, vision, and executive control in HF patients.
- 1 April 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (4) , 883-892
Intravenous Alteplase Versus Best Medical Therapy for Patients With Minor Stroke: A Systematic Review and Meta-Analysis
BACKGROUND: The efficacy of thrombolysis (IVT) in minor stroke (National Institutes of Health Stroke Scale score, 0–5) remains inconclusive. The aim of this study is to compare the effectiveness and safety of IVT with best medical therapy (BMT) by means of a systematic review and meta-analysis of randomized controlled trials and observational studies. METHODS: We searched the PubMed, Embase, Cochrane Library, and Web of Science databases to obtain articles related to IVT in minor stroke from inception until August 10, 2023. The primary outcome was an excellent functional outcome, defined as a modified Rankin Scale score of 0 or 1 at 90 days. The associations were calculated for the overall and preformulated subgroups by using the odds ratios (ORs). This study was registered with PROSPERO (CRD42023445856). RESULTS: A total of 20 high-quality studies, comprised of 13 397 patients with acute minor ischemic stroke, were included. There were no significant differences observed in the modified Rankin Scale scores of 0 to 1 (OR, 1.10 [95% CI, 0.89–1.37]) and 0 to 2 (OR, 1.16 [95% CI, 0.95–1.43]), mortality rates (OR, 0.67 [95% CI, 0.39–1.15]), recurrent stroke (OR, 0.89 [95% CI, 0.57–1.38]), and recurrent ischemic stroke (OR, 1.09 [95% CI, 0.68–1.73]) between the IVT and BMT group. There were differences between the IVT group and the BMT group in terms of early neurological deterioration (OR, 1.81 [95% CI, 1.17–2.80]), symptomatic intracranial hemorrhage (OR, 7.48 [95% CI, 3.55–15.76]), and hemorrhagic transformation (OR, 4.73 [95% CI, 2.40–9.34]). Comparison of modified Rankin Scale score of 0 to 1 remained unchanged in subgroup patients with nondisabling deficits or compared with those using antiplatelets. CONCLUSIONS: These findings indicate that IVT does not yield significant improvement in the functional prognosis of patients with acute minor ischemic stroke. Additionally, it is associated with an increased risk of symptomatic intracranial hemorrhage when compared with the BMT. Moreover, IVT may not have superiority over BMT in patients with nondisabling deficits or those using antiplatelets.
- 1 April 2024
- Published by Wolters Kluwer Health in Stroke
- Vol. 55 (4) , 883-892
Intravenous Alteplase Versus Best Medical Therapy for Patients With Minor Stroke: A Systematic Review and Meta-Analysis
BACKGROUND: The efficacy of thrombolysis (IVT) in minor stroke (National Institutes of Health Stroke Scale score, 0–5) remains inconclusive. The aim of this study is to compare the effectiveness and safety of IVT with best medical therapy (BMT) by means of a systematic review and meta-analysis of randomized controlled trials and observational studies. METHODS: We searched the PubMed, Embase, Cochrane Library, and Web of Science databases to obtain articles related to IVT in minor stroke from inception until August 10, 2023. The primary outcome was an excellent functional outcome, defined as a modified Rankin Scale score of 0 or 1 at 90 days. The associations were calculated for the overall and preformulated subgroups by using the odds ratios (ORs). This study was registered with PROSPERO (CRD42023445856). RESULTS: A total of 20 high-quality studies, comprised of 13 397 patients with acute minor ischemic stroke, were included. There were no significant differences observed in the modified Rankin Scale scores of 0 to 1 (OR, 1.10 [95% CI, 0.89–1.37]) and 0 to 2 (OR, 1.16 [95% CI, 0.95–1.43]), mortality rates (OR, 0.67 [95% CI, 0.39–1.15]), recurrent stroke (OR, 0.89 [95% CI, 0.57–1.38]), and recurrent ischemic stroke (OR, 1.09 [95% CI, 0.68–1.73]) between the IVT and BMT group. There were differences between the IVT group and the BMT group in terms of early neurological deterioration (OR, 1.81 [95% CI, 1.17–2.80]), symptomatic intracranial hemorrhage (OR, 7.48 [95% CI, 3.55–15.76]), and hemorrhagic transformation (OR, 4.73 [95% CI, 2.40–9.34]). Comparison of modified Rankin Scale score of 0 to 1 remained unchanged in subgroup patients with nondisabling deficits or compared with those using antiplatelets. CONCLUSIONS: These findings indicate that IVT does not yield significant improvement in the functional prognosis of patients with acute minor ischemic stroke. Additionally, it is associated with an increased risk of symptomatic intracranial hemorrhage when compared with the BMT. Moreover, IVT may not have superiority over BMT in patients with nondisabling deficits or those using antiplatelets.
- Open Access
- 21 June 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (9) , 2995-2999
Two mechanical thrombectomies in acute ischemic stroke within 48 hours: A case report on a patient with atrial fibrillation
- 21 June 2023
- Published by Elsevier in Radiology Case Reports
- Vol. 18 (9) , 2995-2999
Open AccessTwo mechanical thrombectomies in acute ischemic stroke within 48 hours: A case report on a patient with atrial fibrillation